NASDAQ: ASTH
Astrana Health Inc Stock

$38.38+0.00 (+0%)
Updated Jun 16, 2026
ASTH Price
$38.38
Fair Value Price
N/A
Market Cap
$2.14B
52 Week Low
$18.08
52 Week High
$40.13
P/E
61.9x
P/B
2.67x
P/S
0.39x
PEG
1.06x
Dividend Yield
N/A
Revenue
$3.53B
Earnings
$30.23M
Gross Margin
10.7%
Operating Margin
3.05%
Profit Margin
0.9%
Debt to Equity
2.23
Operating Cash Flow
$166M
Beta
1.24
Next Earnings
Aug 6, 2026
Ex-Dividend
N/A
Next Dividend
N/A

ASTH Overview

Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc. in February 2024, is a healthcare management firm based in Alhambra, California, founded in 1985. This company delivers medical services throughout the United States, operating with a physician-centered approach powered by advanced technology. Its operations are structured across three distinct divisions: Care Partners, Care Delivery, and Care Enablement. Astrana Health utilizes its exclusive platform for population health management and healthcare delivery to implement an integrated, value-based care model. This strategic approach empowers the healthcare providers within its network to offer high-quality care to their patients. The organization provides extensive care coordination services to a broad spectrum of stakeholders, including patients, their families, primary care physicians, specialists, acute care hospitals, other inpatient facilities, physician groups, and health plans. Its robust physician network encompasses primary care doctors, specialized practitioners, advanced practice providers (extenders), and hospital-based physicians. Astrana Health serves a diverse patient base, primarily those with insurance coverage—such as private plans, Medicare, Medicaid, and HMOs—but also extends care to uninsured individuals.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine ASTH's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical Care Facility

Industry Rating
A
ASTH
Ranked
#27 of 40

Top Ranked Stocks in Industry

View Top Medical Care Facility Stocks

Be the first to know about important ASTH news, forecast changes, insider trades & much more!

ASTH News

Overview

Due Diligence Score

Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ASTH scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ASTH ($38.38) is trading above its intrinsic value of $15.62, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ASTH is poor value based on its earnings relative to its share price (61.9x), compared to the US market average (13.25x)
P/E vs Market Valuation
ASTH is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more ASTH due diligence checks available for Premium users.

Valuation

ASTH price to earnings (PE)

For valuing profitable companies with steady earnings

Company
61.9x
Industry
15.21x
Market
13.25x
ASTH is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ASTH is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

ASTH price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
2.67x
Industry
4.9x
ASTH is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ASTH price to earnings growth (PEG)

For valuing profitable companies with growth potential

ASTH is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

ASTH's financial health

Profit margin

Revenue
$965.1M
Net Income
$14.4M
Profit Margin
1.5%
ASTH's Earnings (EBIT) of $107.68M... subscribe to Premium to read more.
Interest Coverage Financials
ASTH's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$2.4B
Liabilities
$1.8B
Debt to equity
2.23
ASTH's short-term assets ($1.00B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ASTH's long-term liabilities ($1.04B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ASTH's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
ASTH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$68.1M
Investing
-$2.8M
Financing
-$16.0M
ASTH's operating cash flow ($166.03M)... subscribe to Premium to read more.
Debt Coverage Financials

ASTH vs Medical Care Facility Stocks

TickerZen RatingMarket Cap1d %P/EP/B
ASTHC$2.14B0.00%61.90x2.67x
SEM$2.06B-0.24%15.67x1.17x
MDA$1.98B-0.90%11.56x2.26x
SGRYC$1.98B+0.07%-25.66x1.17x
ACHCC$2.30B0.00%-2.05x1.17x

Astrana Health Stock FAQ

What is Astrana Health's quote symbol?

(NASDAQ: ASTH) Astrana Health trades on the NASDAQ under the ticker symbol ASTH. Astrana Health stock quotes can also be displayed as NASDAQ: ASTH.

If you're new to stock investing, here's how to buy Astrana Health stock.

What is the 52 week high and low for Astrana Health (NASDAQ: ASTH)?

(NASDAQ: ASTH) Astrana Health's 52-week high was $40.13, and its 52-week low was $18.08. It is currently -4.36% from its 52-week high and 112.28% from its 52-week low.

How much is Astrana Health stock worth today?

(NASDAQ: ASTH) Astrana Health currently has 55,716,220 outstanding shares. With Astrana Health stock trading at $38.38 per share, the total value of Astrana Health stock (market capitalization) is $2.14B.

Astrana Health stock was originally listed at a price of $10.00 in Dec 8, 2017. If you had invested in Astrana Health stock at $10.00, your return over the last 8 years would have been 283.8%, for an annualized return of 18.31% (not including any dividends or dividend reinvestments).

How much is Astrana Health's stock price per share?

(NASDAQ: ASTH) Astrana Health stock price per share is $38.38 today (as of Jun 16, 2026).

What is Astrana Health's Market Cap?

(NASDAQ: ASTH) Astrana Health's market cap is $2.14B, as of Jun 17, 2026.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Astrana Health's market cap is calculated by multiplying ASTH's current stock price of $38.38 by ASTH's total outstanding shares of 55,716,220.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.